Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Fuchs Henry J
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   222,228    

Indirect Shares

   0      
Direct Value   $18,063,061    

Indirect Value

   $0      
Total Shares   222,228      
Total Value   $18,063,061      


Onyx Pharmaceuticals Inc $0 Biomarin Pharmaceutical Inc $17,448,765 Mirati Therapeutics, Inc. $614,296 Onyx Pharmaceuticals Inc $0 Biomarin Pharmaceutical Inc $17,448,765 Mirati Therapeutics, Inc. $614,296
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Onyx Pharmaceuticals Inc ONXX EVP & Chief Medical Of... 2008-11-18 14,891 2006-05-15 0    Premium*  
            Ardea Biosciences Inc RDEA Director 2012-06-19 0 2007-12-05 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN President, Worldwide R&D 2024-03-15 196,872 2009-03-02 0    Premium*  
            Genomic Health Inc GHDX Director 2019-11-08 0 2014-04-01 0    Premium*  
            Mirati Therapeutics, Inc. MRTX 2023-01-20 10,465 2020-01-03 0    Premium*  
* Premium Members only  

Records found :    294         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 7 of 12
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-04-02 4 AS $34.08 $170,380 D/D (5,000) 36,611 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-04-02 4 OE $11.05 $55,250 D/D 5,000 41,611 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-05-01 4 AS $34.99 $174,950 D/D (5,000) 30,018 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-05-01 4 OE $11.05 $55,250 D/D 5,000 35,018 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-06-01 4 AS $35.02 $175,078 D/D (5,000) 52,277 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-06-01 4 OE $11.05 $55,250 D/D 5,000 57,277 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-08-01 4 OE $11.05 $55,250 D/D 5,000 57,277 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-08-01 4 AS $38.63 $193,145 D/D (5,000) 52,277 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-09-04 4 OE $11.05 $55,250 D/D 5,000 57,277 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-09-04 4 AS $37.76 $188,791 D/D (5,000) 52,277 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-10-01 4 AS $39.75 $198,760 D/D (5,000) 52,277 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-10-01 4 OE $11.05 $55,250 D/D 5,000 57,277 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-11-01 4 AS $37.08 $185,384 D/D (5,000) 52,277 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2012-11-01 4 OE $11.05 $55,250 D/D 5,000 57,277 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-03-15 4 D $92.50 $473,230 D/D (5,116) 120,402 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-03-22 4 D $81.36 $472,864 D/D (5,812) 156,676 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2010-04-01 4 OE $11.05 $64,455 D/D 5,833 25,833 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2010-04-01 4 S $24.00 $139,974 D/D (5,833) 20,000 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-03-22 4/A D $81.36 $474,736 D/D (5,835) 156,653 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2019-03-22 4 D $88.05 $513,860 D/D (5,836) 130,468 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2020-03-20 4 D $73.05 $426,320 D/D (5,836) 139,869 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2019-03-25 4 AS $87.86 $521,186 D/D (5,932) 124,536 0 -
RDEA Ardea Biosciences Inc Director   –       •      –    2010-01-11 4 AS $15.83 $94,954 D/D (6,000) 10,416 0 -
RDEA Ardea Biosciences Inc Director   –       •      –    2010-01-11 4 OE $2.76 $16,560 D/D 6,000 16,416 0 -
ONXX Onyx Pharmaceuticals Inc EVP & Chief Medical Officer   •       –      –    2008-06-23 4 OE $21.01 $131,313 D/D 6,250 23,225 0 -
  294  Records found
  1   2   3   4   5   6   7  8   9   10   11   12      
  Page 7 of 12  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us